Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ZG-802 by Zeria Pharmaceutical for Hypoactive Bladder: Likelihood of Approval
ZG-802 is under clinical development by Zeria Pharmaceutical and currently in Phase II for Hypoactive Bladder. According to GlobalData, Phase...
Data Insights
Acotiamide hydrochloride by Zeria Pharmaceutical for Functional (Non Ulcer) Dyspepsia: Likelihood of Approval
Acotiamide hydrochloride is under clinical development by Zeria Pharmaceutical and currently in Phase III for Functional (Non Ulcer) Dyspepsia. According...